Delivery Order SPE2DB22D3004-SPE2DB24FRS97

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Premarin 1.25 mg tablets in 100-count packages, with a ceiling value of $1,681.65 and a period of performance through November 2024. The contract is a firm-fixed-price arrangement, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100-count bottles of the drug Premarin 0.625 mg tablets. The contract has a firm fixed price of $5,651.27 and a completion date of November 29, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,421.04, is for the delivery of Premarin 0.625 mg tablets. The contract has a completion date of February 7, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.625 mg tablets. The contract has a ceiling value of $2,417.34 and an ultimate completion date of May 2, 2025. The contract is not set aside and was awarded on May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.625 mg tablets. The contract has a ceiling value of $13,027.95 and a period of performance running through May 20, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
This is a $2,763.81 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.9 mg tablets. The contract has a completion date of September 13, 2024 and is not set aside for any specific business category. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a wide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 1.25 mg tablets. The contract has a firm fixed price of $1,641.15 and an ultimate completion date of October 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Premarin 0.9 mg tablets in 100-count packages, with a total ceiling value of $1,830.50 and a performance period ending on June 16, 2025. The contract is a firm-fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,402.87, is for the delivery of Premarin 0.625 mg tablets. It is a firm fixed-price contract with a performance period ending on May 8, 2025. The contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.625 mg tablets. The award is not set aside and has a ceiling value of $1,956.51. The period of performance extends through August 30, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a range of...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRS97
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to the pharmaceutical distributor AmerisourceBergen Drug Corporation for the supply of Premarin 1.25 mg tablets in 100-count packages. The contract has a ceiling value of $7,158.85 and a completion date of September 6, 2024. It is a firm-fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999, for providing a range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/5/24, 10:37 AM